GANZIMMUN DIAGNOSTICS AG

What GANZIMMUN DIAGNOSTICS AG does

GANZIMMUN DIAGNOSTICS AG, operating through MVZ GANZIMMUN GmbH, is a German medical diagnostic laboratory founded in 1998 and headquartered in Mainz. The company provides specialized laboratory diagnostic services across more than 4,000 parameters spanning allergy, endocrinology, genetic diagnostics, immunodiagnostics, infectious disease, cardiovascular, gastrointestinal, mitochondrial, neuroendocrine, toxicology, and food intolerance testing. Its core technology platforms include LC-MS, Next-Generation Sequencing, cell culture, and multiplex ELISA testing, supported by the proprietary 2D-connect® electronic laboratory management system that handles order intake, sample tracking, and result delivery. Notable proprietary diagnostic products include the ALEX3 multiplex allergy screening system (82 allergen extracts and 218 molecular components), ColoAlert molecular colorectal cancer screening, MitoCount-Test and MitoStress plus mitochondrial diagnostics, and microbiome analytics including Urolithin A metabotyping.

The business operates a B2B model in which physicians, Heilpraktiker (alternative practitioners), pharmacists, and other healthcare providers order diagnostic tests on behalf of patients, with revenue generated per order through laboratory services billed to patients, health insurance, or private payors. GANZIMMUN deploys a nationwide scientific field sales force (Außendienst) together with an in-house sample logistics (Fahrdienst) network and digital result delivery to embed its services into the workflow of medical practices across Germany, Austria, Switzerland, France, the Netherlands, Czech Republic, and Slovakia. The company complements its testing services with the GANZIMMUN-Akademie and GANZIMMUN-Mediathek, an education ecosystem of 200+ annual seminars and 400+ on-demand videos across 17 medical categories.

GANZIMMUN is a privately held company with no disclosed parent or external institutional ownership, led by Managing Director Dr. med. Patrik Zickgraf for over 25 years. The company holds DIN EN ISO 15189 and DIN EN ISO/IEC 17025 accreditation verified by DAkkS, and operates from a new 7,900 square meter KfW 55-certified facility at Mainz Lerchenberg occupied since January 2025 with 470+ interdisciplinary staff processing approximately 5,500 orders daily. The company is referenced within the broader Limbach Gruppe laboratory network, positioning it within a national specialty diagnostics ecosystem while maintaining its independent brand and complementary medicine orientation.

Name

GANZIMMUN DIAGNOSTICS AG

Legal name

MVZ GANZIMMUN GmbH

Website

https://ganzimmun.de

Company type

Private

Founded year

1998

Operating status

Operating

Headcount range

51–100 employees

Short description

GANZIMMUN DIAGNOSTICS AG is a German medical laboratory founded in 1998 that provides over 4,000 specialized diagnostic parameters across allergy, genetics, mitochondrial, microbiome, and preventive medicine for physicians, alternative practitioners, pharmacists, and patients across DACH and broader Europe.

Ownership category

akta.pro rank

Product category

Medical Laboratory Diagnostics

NAICS

Medical Laboratories (621511), Medical and Diagnostic Laboratories (6215)

SIC

Services-Medical Laboratories (8071)

akta.pro primary industry

Reference & Esoteric Testing Laboratories (HLAFAMAJ)

akta.pro secondary industries

Molecular Diagnostics & Genomics Laboratories (HLAFAMAE), Genetic & Genomic Testing (germline, somatic, carrier, pharmacogenomics) (HLAAALAD), Microbiology & Infectious Disease Testing Laboratories (HLAFAMAD)

Keywords

• Medical laboratory diagnostics
• Allergy diagnostics services
• Preventive diagnostics testing
• Clinical laboratory services
• Genetic diagnostics testing

Headquarters

HQ city

Mainz

HQ country

Germany

HQ region

Europe

Offices1 record

Markets served

GTM type

B2B

Offering type

Services

Cost components

Personnel, Operations, Technology or R&D, Infrastructure, Marketing or Sales, Supply Chain

Revenue model

1. Laboratory Diagnostic Services: Medical laboratory offering over 4,000 diagnostic parameters for physicians, therapists, and patients. Revenue generated through laboratory testing services billed to patients, health insurance, or private payors based on medical necessity orders from healthcare providers.

Go-to-market motion2 records

Distribution channels4 records

Marketing channels8 records

Core offering

GANZIMMUN DIAGNOSTICS AG operates a medical diagnostic laboratory offering over 4,000 diagnostic parameters to physicians, therapists, and patients across Germany, Austria, Switzerland, and other European countries. The company provides comprehensive laboratory analyses spanning allergy, endocrinology, genetic diagnostics, immunodiagnostics, infectious disease, cardiovascular, gastrointestinal, mitochondrial, neuroendocrine, toxicology, and food intolerance testing. Services are supported by proprietary technology platforms including the 2D-connect lab management system, mobile app access, and result notification systems, with samples collected via company-operated logistics from medical practices.

Product overview

GANZIMMUN DIAGNOSTICS AG operates as a medical diagnostic laboratory offering a comprehensive portfolio of over 4,000 diagnostic parameters. The core offering consists of laboratory diagnostic services spanning allergy, endocrinology, genetic diagnostics, immunodiagnostics, infectious disease, cardiovascular, gastrointestinal, mitochondrial, neuroendocrine, toxicology, and food intolerance testing. The product portfolio is supported by proprietary technology platforms including 2D-connect® (electronic lab management system), GANZIMMUN-App (mobile access), and Befundbenachrichtigungssystem (result notification) for digital result transmission. Education services are provided through the GANZIMMUN-Akademie with its GANZIMMUN-Mediathek containing 400+ educational videos. Key diagnostic products include ALEX3 for molecular allergy diagnostics, ColoAlert for colorectal cancer screening, MitoCount-Test and MitoStress plus for mitochondrial diagnostics, and specialized tests for Urolithin A microbiome analysis and Filaggrin genotyping. Results are delivered through Isylab (value-focused reports) and MVS (detailed interpretive reports with therapy recommendations).

Differentiator

Problem solved

Functional benefit

Brands

• 2D-connect®: Electronic laboratory management system developed by GANZIMMUN for managing laboratory operations and results transmission.
• GANZIMMUN-Mediathek
• GANZIMMUN-Akademie
• ColoAlert
• ALEX

Products and services

• 2D-connect® Labormanagementsystem

Quantifiable outcome

• 5,500 diagnostic orders processed daily
• +3 more outcomes

Named customers4 records

Segments4 records

Ideal customer profiles4 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature5 records

Partnerships

Two partnerships are on record, tiered core and minor.

• St. Leonhards AkademiecoreStrategic or Co-development Partner · 1 January 2026Strategic partnership for the annual DETOX Fachsymposium. St. Leonhards Akademie co-organizes the educational event held at Kloster Seeon, combining medical education with complementary medicine approaches. The partnership features first-class speakers and branch-specific exhibitors.
• Limbach GruppeminorOthers · 1 January 2021Limbach Gruppe referenced as a partner entity in the context of the GANZIMMUN Diagnostics building project. The company operates as part of the broader Limbach network of laboratories.

Scale indicators7 records

Recent moves7 records

Expansion highlights5 records

Direct peers

• Synlab AG: Europe's largest medical diagnostics provider offering routine and specialty testing to physicians and hospitals across 30+ countries, including an extensive German/DACH network with similar B2B physician-referral economics.
• Unilabs: Pan-European clinical laboratory and diagnostics provider with significant German/DACH operations, offering routine and specialized testing to referring physicians under similar reimbursement dynamics.
• Medicover: European healthcare and diagnostics services provider active in Germany, Poland, CEE, and beyond — offering clinical laboratory testing and preventive diagnostics with similar physician-channel exposure.
• Limbach Gruppe: German network of specialized medical laboratories serving physicians and hospitals; explicitly referenced as a partner/network relationship to GANZIMMUN, with overlapping specialty diagnostics and physician-focused model.
• amedes Group: German-headquartered diagnostics and healthcare group delivering laboratory, medical, and specialty testing to physicians and patients across Europe — directly overlapping in physician-ordered specialty diagnostics.
• MVZ Medizinische Labore (LADR network): Physician-owned German laboratory network (LADR) providing specialty and routine diagnostics across Germany; comparable B2B physician-referral model and Germanic regulatory environment.

Emerging players

• Biovis Diagnostik: German specialty immunology and integrative medicine laboratory offering targeted esoteric tests to Heilpraktiker and physicians — overlapping with GANZIMMUN's complementary/preventive diagnostics niche.
• IMD Institut für Medizinische Diagnostik: Berlin-based German reference laboratory offering specialized clinical diagnostics (endocrinology, immunology, infectious disease) — comparable specialty/esoteric testing positioning to GANZIMMUN within the German physician referral market.

Broad incumbents

• Sonic Healthcare: Global medical diagnostics incumbent operating extensive laboratory networks across Europe (including Germany) and offering a broad routine/specialty test menu overlapping with GANZIMMUN's esoteric focus at a much larger scale.
• Helios Laboratory / Fresenius Lab Services: Major German hospital-linked diagnostic providers delivering routine and specialty testing; competitive overlap in physician-ordered laboratory services, particularly in regional German markets.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat6 records

Key risks6 records

Key highlights7 records

Customer concentration

• Facebookfacebook.com/ganzimmun
• LinkedInde.linkedin.com/company/ganzimmun-diagnostics-ag
• Instagraminstagram.com/ganzimmun

Compliance1 record

Revenue estimate

Valuation estimate

Number of profiles

Profiles1 record

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about GANZIMMUN DIAGNOSTICS AG